CD19, CD69, CD8, and CD86 were significantly higher in IPF patients than in controls (p = 0.0023, p = 0.0471, p = 0.0082, and p = 0.0143, respectively) (Figure 3c). This evidence concerns the gene CD19 and idiopathic pulmonary fibrosis.